D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 107 Citations 46,100 414 World Ranking 2744 National Ranking 1591

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

His primary scientific interests are in Pathology, Glioma, Cancer research, Meningioma and Astrocytoma. His Pathology research integrates issues from Fluorescence in situ hybridization, Monosomy and Gene expression profiling. His Glioma study deals with Internal medicine intersecting with Selumetinib and Gastroenterology.

His study in Cancer research is interdisciplinary in nature, drawing from both Tumor suppressor gene, Oncogene and Mutation. His study in the field of Benign Meningioma also crosses realms of Mitotic index. His Astrocytoma research includes themes of ATRX and Ganglioglioma.

His most cited work include:

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors (938 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Pathology, Meningioma, Glioma, Immunohistochemistry and Cancer research. Arie Perry works in the field of Pathology, namely Neurofibromatosis. His work deals with themes such as Merlin and Oncology, which intersect with Meningioma.

The various areas that Arie Perry examines in his Glioma study include Brain tumor and Internal medicine. His Immunohistochemistry study frequently draws connections between adjacent fields such as Differential diagnosis. His Cancer research research incorporates themes from Mutation and Tumor suppressor gene.

He most often published in these fields:

  • Pathology (57.81%)
  • Meningioma (15.98%)
  • Glioma (15.98%)

What were the highlights of his more recent work (between 2016-2021)?

  • Pathology (57.81%)
  • Meningioma (15.98%)
  • Internal medicine (11.31%)

In recent papers he was focusing on the following fields of study:

Arie Perry focuses on Pathology, Meningioma, Internal medicine, Oncology and Cancer research. His Pathology research is multidisciplinary, incorporating elements of Astrocytoma, Glioma and Magnetic resonance imaging. His Meningioma study combines topics from a wide range of disciplines, such as Transcriptome, Local failure and Proportional hazards model.

As part of one scientific family, Arie Perry deals mainly with the area of Oncology, narrowing it down to issues related to the ATRX, and often CDKN2A. His Cancer research study incorporates themes from Mutation, Missense mutation and Epigenetics. Arie Perry has researched Mutation in several fields, including DNA methylation and Exon.

Between 2016 and 2021, his most popular works were:

  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • Primary brain tumours in adults. (252 citations)
  • cIMPACT-NOW Update 3: Recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (228 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Arie Perry spends much of his time researching Pathology, Meningioma, Internal medicine, Glioma and Oncology. Arie Perry connects Pathology with Extramural in his research. Arie Perry interconnects Local failure, Resection, Recursive partitioning and Nomogram in the investigation of issues within Meningioma.

The Internal medicine study combines topics in areas such as Gastroenterology, Anaplastic astrocytoma and Selumetinib. His Glioma research incorporates elements of Not Otherwise Specified, IDH1 R132H and Psychoanalysis. His Oncology research is multidisciplinary, incorporating perspectives in Diffuse Astrocytoma, Clinical trial, Retrospective cohort study and ATRX.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling.
Acta Neuropathologica (2016)

8837 Citations

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh.
The New England Journal of Medicine (2015)

1274 Citations

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas

Justin S. Smith;Arie Perry;Thomas J. Borell;Hyun K. Lee.
Journal of Clinical Oncology (2000)

921 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

Meningioma grading: an analysis of histologic parameters.

Arie Perry;Scott L. Stafford;Bernd W. Scheithauer;Vera J. Suman.
The American Journal of Surgical Pathology (1997)

679 Citations

International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

David N. Louis;Arie Perry;Peter Burger;David W. Ellison.
Brain Pathology (2014)

593 Citations

Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott.
Cancer Cell (2014)

561 Citations

Notch1 and notch2 have opposite effects on embryonal brain tumor growth.

Xing Fan;Irina Mikolaenko;Ihab Elhassan;Xing Zhi Ni.
Cancer Research (2004)

504 Citations

Histological classification and molecular genetics of meningiomas

Markus J Riemenschneider;Arie Perry;Guido Reifenberger.
Lancet Neurology (2006)

503 Citations

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups

David W. Ellison;James Dalton;Mehmet Kocak;Sarah Leigh Nicholson.
Acta Neuropathologica (2011)

483 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Arie Perry

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 399

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 297

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 197

David H. Gutmann

David H. Gutmann

Washington University in St. Louis

Publications: 189

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 168

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 166

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 160

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 159

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 142

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 116

Michael Weller

Michael Weller

University of Zurich

Publications: 112

Torsten Pietsch

Torsten Pietsch

University of Bonn

Publications: 109

Dominique Figarella-Branger

Dominique Figarella-Branger

Aix-Marseille University

Publications: 105

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 104

Charles G. Eberhart

Charles G. Eberhart

Johns Hopkins University School of Medicine

Publications: 95

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 95

Trending Scientists

Dharmendra S. Modha

Dharmendra S. Modha

IBM (United States)

Jonathan Haskel

Jonathan Haskel

Imperial College London

Jan Drewes Achenbach

Jan Drewes Achenbach

Northwestern University

Dietrich A. Volmer

Dietrich A. Volmer

Saarland University

Igor V. Koptyug

Igor V. Koptyug

Novosibirsk State University

Colin A. Fyfe

Colin A. Fyfe

University of British Columbia

Xiaoqiao He

Xiaoqiao He

City University of Hong Kong

Xingbin Yan

Xingbin Yan

Sun Yat-sen University

Erik A. Beever

Erik A. Beever

United States Geological Survey

Zu-Hang Sheng

Zu-Hang Sheng

National Institutes of Health

Aurore Voldoire

Aurore Voldoire

Federal University of Toulouse Midi-Pyrénées

Beate Hermelin

Beate Hermelin

Goldsmiths University of London

Edward D. Levin

Edward D. Levin

Duke University

Tone Bjørge

Tone Bjørge

University of Bergen

Michel Treisman

Michel Treisman

University of Oxford

Rodolfo Baggio

Rodolfo Baggio

Bocconi University

Something went wrong. Please try again later.